75R60223F34006↗

The Bizzell Group LLC received this contract from Hrsa Headquarters, Health Resources and Services Administration: $20.22M obligated so far for support- professional: engineering/technical. It runs to 2027-08-31, or to 2028-08-31 if every option is exercised.

Key facts · data as of Oct 25, 2026

Recipient
The Bizzell Group LLC
Awarding agency
Health Resources and Services Administration (Department of Health and Human Services)
Contracting office
Hrsa Headquarters (75R602)
Obligated to date
$20.22M
Potential value
$25.39M
Ends
2027-08-31

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.

Cite this page: SpendQuery, Award 75R60223F34006, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75R60223F34006_7526_75R60219D00045_7526

OSHI193 C 4722 OFFICE OF PHARMACY AFFAIRS - 340B AUDITS

Delivery Order · Health Resources and Services Administration · to The Bizzell Group LLC (UEI KGJUK3TUQ416) · data as of 2026-10-25

Obligated to date$20.22M8 actions
Current value$20.22Mwith options exercised
Potential value$25.39Mif every option is used
Period2023-09-01 → 2027-08-31up to 2028-08-31 with options

Up for re-bid: ends 2027-08-31. Recompete brief →

What it is

Product or service
Support- Professional: Engineering/Technical (PSC R425)
Industry
Administrative Management and General Management Consulting Services (NAICS 541611)
Contracting office
Hrsa Headquarters (75R602)
Competition
Full and open competition · 1 offer received
Pricing
Firm fixed price
How it was bought
Multiple-award IDIQ · under 75R60219D00045
Solicitation
75R60223Q00154
Where the work is
Prince Georges, MD · district MD-04

Obligations by fiscal year

FY2023$4.97M
FY2024$5.03M
FY2025$5.08M
FY2026$5.13M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

8 actions since 2023-08-24. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2026-08-31P00007Option exercised$5.13M4CAST ID: OSHI193 C 4722. TITLE: OFFICE OF PHARMACY AFFAIRS 340B AUDITS. AWARD TYPE: FIRM FIXED PRICE
2025-07-23P00006Option exercised$5.08MOSHI193 C 4722. OFFICE OF PHARMACY AFFAIRS 340B AUDITS.
2025-05-08P00005Administrative change$0OSHI193 C 4722. OFFICE OF PHARMACY AFFAIRS 340B AUDITS.
2024-09-06P00004Supplemental agreement (work within scope)$0OSHI193 C 4722. OFFICE OF PHARMACY AFFAIRS 340B AUDITS.
2024-07-16P00003Option exercised$5.03MOSHI193 C 4722. OFFICE OF PHARMACY AFFAIRS 340B AUDITS.
2024-05-10P00002Administrative change$0OSHI193 C 4722. OFFICE OF PHARMACY AFFAIRS 340B AUDITS.
2023-11-13P00001Administrative change$0OSHI193 C 4722. OFFICE OF PHARMACY AFFAIRS 340B AUDITS.
2023-08-240$4.97MOSHI193 C 4722 OFFICE OF PHARMACY AFFAIRS - 340B AUDITS

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗